Stocks to watch: MMHE, Boustead, CIMB, Pharmaniaga

KUALA LUMPUR: The selldown on Bursa Malaysia on Tuesday, Oct 18, in line with the regional markets, saw RM21.9 billion erased from the Malaysian stock market capitalisation, according to the stock market data.

The sharp pullback was expected to push investors to the sidelines on Wednesday, unless there was strong economic data from the US or Europe to restore confidence.

Analysts expect trading to be volatile on Wednesday with more downside pressure, if Wall Street extends its losses on Tuesday.

At Bursa Malaysia, the FBM KLCI fell 1.73% or 25.41 points to 1,439.94, weighed by losses including at PLANTATION []s and blue chip stocks. Losers hammered gainers 705 to 145 while volume was 1.36 billion shares valued at RM1.37 billion.

Sime Darby’s 25 sen decline to RM8.65, dragged the 30-stock index down by 3.47 points while CIMB’s loss of 18 sen to RM7.19 erased 3.10 points from the index. Tenaga fell 22 sen to RM5.35, giving up most of Monday’s gains, reduced the index by another 2.75 points.

On the regional front, Hong Kong’s Hang Seng Index tumbled 4.23% to 18,076.46, the Shanghai Composite Index lost 2.33% to 2,383.49, Singapore’s Straits Times Index fell 1.95% to 2,724.69, Japan’s Nikkei 225 was down 1.55% to 8,741.91, South Korea’s Kospi lost 1.41% to 1,838.90 and Taiwan’s Taiex shed 1.36% to 7,359.48.

At Bursa, stocks to watch on Wednesday are BOUSTEAD HOLDINGS BHD [], Pharmaniaga, Malaysia Marine and Heavy Engineering Holdings Bhd (MMHE) and CIMB Group Holdings Bhd.

Boustead Holdings Bhd is seeking RM20.80 million in compensation after the Penang government decided not to approve the reclamation plans.

Boustead said the compensation amount was verified by independent consultants and it “is still in negotiation with the Penang Chief Minister and state government on the form of compensation to be paid to Boustead Holdings”.

In a separate announcement, Boustead reduced the offer price for PHARMANIAGA BHD [] shares by 5% from RM5.75 to RM5.46 under the restricted offer due to the prevailing market conditions.

It said the price of RM5.46 per Pharmaniaga share represented an attractive entry level cost into Pharmaniaga.

Boustead cited the relatively stable income stream for Pharmaniaga from the concession held by Pharmaniaga for the distribution of selected medical products to government owned hospitals and the growth prospects of the pharmaceutical industry in Malaysia.

MMHE’s unit has secured a contract for the Teluk gas development project by ExxonMobil Exploration and Production Malaysia Inc.

It saidthe scope of work included the CONSTRUCTION [] to commissioning of two top sides and two jackets to support the platforms.

CIMB Group Holdings Bhd’s subsidiary CIMB Thai posted net profit of 856.1 million baht (RM87.26 million) in the nine-months ended Sept 30, 2011, down 4.2% from 893.6 million baht in the previous corresponding period.

CIMB Thai, a 93.15% of CIMB Bank Bhd, reported on Tuesday, Oct 18 this was mainly due to one-off gains from the disposal of Sathorn building and certain subsidiaries in the corresponding period in 2010. “Should these items be excluded, the profit would have increased 149.2% year-on-year,” it said.